Samsung Biologics Co.,Ltd. (KRX:207940)
1,182,000
-24,000 (-1.99%)
Oct 14, 2026, 3:30 PM KST
Samsung Biologics Employees
Samsung Biologics had 5,326 employees as of June 30, 2026. The number of employees increased by 279 or 5.53% compared to the same quarter last year. That makes Samsung Biologics the 5,399th largest employer in the world and 43rd in South Korea.
Employees
5,326
Change (1Y)
279
Growth (1Y)
5.53%
Revenue / Employee
961.55M KRW
Profits / Employee
372.57M KRW
Market Cap
54.66T
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 5,326 | 279 | 5.53% |
| Jun 30, 2025 | 5,047 | 303 | 6.39% |
| Dec 31, 2024 | 4,770 | 486 | 11.34% |
| Sep 30, 2024 | 4,744 | 460 | 10.74% |
| Sep 30, 2023 | 4,284 | - | - |
| Mar 31, 2023 | 4,296 | - | - |
| Mar 31, 2021 | 3,247 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Samsung Biologics News
- 6 weeks ago - Samsung Biologics Publishes PolyPeptide Offer Prospectus; Sets Tender Period - Nasdaq
- 6 weeks ago - Samsung Biologics Plans $2 Billion Fundraising for PolyPeptide Acquisition - GuruFocus
- 6 weeks ago - Samsung Biologics Plans $21.7 Billion Fundraising for Growth Strategy - GuruFocus
- 2 months ago - Samsung Biologics Slides: Q2 2026 - Filings
- 2 months ago - Samsung Biologics Quarterly report: Q2 2026 - Filings
- 2 months ago - Samsung Biologics Delivers Solid Q2 2026 Growth, Operating Profit Rises - Nasdaq
- 2 months ago - Samsung Biologics (005940) Proposes $1.8 Billion Acquisition of Polypeptide Group - GuruFocus
- 2 months ago - Samsung Biologics to Acquire Peptide Group for $1.8 Billion (SMCI) - GuruFocus